FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2900920091> ?p ?o ?g. }

• W2900920091 endingPage "477" @default.
• W2900920091 startingPage "465" @default.
• W2900920091 abstract "This study hypothesized that there is an association between chronic stress (as indexed by resting amygdalar activity [AmygA]), hematopoietic system activity (HMPA), and subclinical cardiovascular indexes (aortic vascular inflammation [VI] and noncalcified coronary plaque burden [NCB]) in psoriasis (PSO). The study also hypothesized that treatment of PSO would improve these parameters. PSO is a stress-related chronic inflammatory condition that is associated with increased prevalence of subclinical cardiovascular disease (CVD). In individuals without PSO, stress has been linked to CVD through a serial biological pathway that involves the amygdala, hematopoietic tissues, and atherosclerotic plaques. A total of 164 consecutive patients with PSO and 47 healthy volunteers underwent 18-fluorodeoxyglucose positron emission tomography/computed tomography scans for assessment of AmygA, HMPA, and VI, as well as coronary computed tomography angiography scans for quantifying NCB. Furthermore, a consecutive subset of 30 patients with severe PSO (Psoriasis Area Severity Index Score >10) were followed at 1 year to assess the relationship between skin disease improvement and AmygA, HMPA, VI, and NCB. The PSO cohort was middle-aged (mean age: 50 years), had low cardiovascular risk (Framingham risk score: median: 3) and had mild to moderate PSO activity (median Psoriasis Area Severity Index Score: 5.6). AmygA was higher in patients with PSO compared to volunteer participants. AmygA was associated with HMPA (bone marrow activity: β = 0.20, p = 0.01) and subclinical CVD (VI: β = 0.31, p < 0.001; NCB: β = 0.27, p < 0.001) The AmygA−CVD association was in part mediated by HMPA (VI: 20.9%, NCB: 36.7%). Following 1 year of PSO treatment in those with severe disease, improvement in skin disease was accompanied by a reduction in AmygA, bone marrow activity, and VI, with no progression of NCB. In PSO, a chronic inflammatory disease state, AmygA, which is a manifestation of chronic stress, substantially contributes to the risk of subclinical CVD. Additional studies that use psychometric measures of stress are required to explore therapeutic impact." @default.
• W2900920091 created "2018-11-29" @default.
• W2900920091 creator A5003760958 @default.
• W2900920091 creator A5004459215 @default.
• W2900920091 creator A5005047752 @default.
• W2900920091 creator A5006290273 @default.
• W2900920091 creator A5007894377 @default.
• W2900920091 creator A5013080271 @default.
• W2900920091 creator A5016965320 @default.
• W2900920091 creator A5020348286 @default.
• W2900920091 creator A5025791584 @default.
• W2900920091 creator A5030606589 @default.
• W2900920091 creator A5032082280 @default.
• W2900920091 creator A5033787787 @default.
• W2900920091 creator A5033795032 @default.
• W2900920091 creator A5037356234 @default.
• W2900920091 creator A5044504500 @default.
• W2900920091 creator A5044522751 @default.
• W2900920091 creator A5044744366 @default.
• W2900920091 creator A5053807316 @default.
• W2900920091 creator A5054047716 @default.
• W2900920091 creator A5057317213 @default.
• W2900920091 creator A5062710712 @default.
• W2900920091 creator A5064404032 @default.
• W2900920091 creator A5066516536 @default.
• W2900920091 creator A5075911442 @default.
• W2900920091 creator A5077687421 @default.
• W2900920091 creator A5086010156 @default.
• W2900920091 creator A5086804964 @default.
• W2900920091 creator A5087435433 @default.
• W2900920091 creator A5088003622 @default.
• W2900920091 date "2020-02-01" @default.
• W2900920091 modified "2023-09-30" @default.
• W2900920091 title "Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis" @default.
• W2900920091 cites W1070499447 @default.
• W2900920091 cites W1899693127 @default.
• W2900920091 cites W1947718272 @default.
• W2900920091 cites W1984996259 @default.
• W2900920091 cites W1987538872 @default.
• W2900920091 cites W2007448220 @default.
• W2900920091 cites W2011140471 @default.
• W2900920091 cites W2022665587 @default.
• W2900920091 cites W2036891077 @default.
• W2900920091 cites W2037806725 @default.
• W2900920091 cites W2044045263 @default.
• W2900920091 cites W2049793540 @default.
• W2900920091 cites W2064509874 @default.
• W2900920091 cites W2067687558 @default.
• W2900920091 cites W2071936488 @default.
• W2900920091 cites W2091204095 @default.
• W2900920091 cites W2092017894 @default.
• W2900920091 cites W2095652983 @default.
• W2900920091 cites W2097499476 @default.
• W2900920091 cites W2099172760 @default.
• W2900920091 cites W2110747672 @default.
• W2900920091 cites W2135646975 @default.
• W2900920091 cites W2137070742 @default.
• W2900920091 cites W2140059376 @default.
• W2900920091 cites W2149257689 @default.
• W2900920091 cites W2152934881 @default.
• W2900920091 cites W2156919621 @default.
• W2900920091 cites W2204146501 @default.
• W2900920091 cites W2324926491 @default.
• W2900920091 cites W2326005976 @default.
• W2900920091 cites W2394997630 @default.
• W2900920091 cites W2575516020 @default.
• W2900920091 cites W2613380263 @default.
• W2900920091 cites W2617191705 @default.
• W2900920091 cites W2781681147 @default.
• W2900920091 cites W3022423927 @default.
• W2900920091 cites W988932408 @default.
• W2900920091 doi "https://doi.org/10.1016/j.jcmg.2018.08.038" @default.
• W2900920091 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6506409" @default.
• W2900920091 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30448131" @default.
• W2900920091 hasPublicationYear "2020" @default.
• W2900920091 type Work @default.
• W2900920091 sameAs 2900920091 @default.
• W2900920091 citedByCount "49" @default.
• W2900920091 countsByYear W29009200912019 @default.
• W2900920091 countsByYear W29009200912020 @default.
• W2900920091 countsByYear W29009200912021 @default.
• W2900920091 countsByYear W29009200912022 @default.
• W2900920091 countsByYear W29009200912023 @default.
• W2900920091 crossrefType "journal-article" @default.
• W2900920091 hasAuthorship W2900920091A5003760958 @default.
• W2900920091 hasAuthorship W2900920091A5004459215 @default.
• W2900920091 hasAuthorship W2900920091A5005047752 @default.
• W2900920091 hasAuthorship W2900920091A5006290273 @default.
• W2900920091 hasAuthorship W2900920091A5007894377 @default.
• W2900920091 hasAuthorship W2900920091A5013080271 @default.
• W2900920091 hasAuthorship W2900920091A5016965320 @default.
• W2900920091 hasAuthorship W2900920091A5020348286 @default.
• W2900920091 hasAuthorship W2900920091A5025791584 @default.
• W2900920091 hasAuthorship W2900920091A5030606589 @default.
• W2900920091 hasAuthorship W2900920091A5032082280 @default.
• W2900920091 hasAuthorship W2900920091A5033787787 @default.
• W2900920091 hasAuthorship W2900920091A5033795032 @default.
• W2900920091 hasAuthorship W2900920091A5037356234 @default.

• next